WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience MBF Bioscience Autoneuron
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (35)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhou, J. Y.
Right arrow Articles by Miller, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhou, J. Y.
Right arrow Articles by Miller, R. J.

 Previous Article  |  Next Article 

The Journal of Neuroscience, October 1, 2000, 20(19):7143-7148

Selective Regulation of N-Type Ca Channels by Different Combinations of G-Protein beta /gamma Subunits and RGS Proteins

Janice Y. Zhou1, David P. Siderovski2, and Richard J. Miller1

1 Department of Neurobiology, Pharmacology, and Physiology, University of Chicago, Chicago, Illinois 60637, and 2 Department of Pharmacology, University of North Carolina, Chapel Hill, North Carolina 27599


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

We examined the effects of G-protein beta  and gamma  subunit heterodimers on human alpha 1B (N-type) Ca channels expressed in HEK293 cells. All of the known beta  subunits (beta 1-beta 5) produced voltage-dependent inhibition of alpha 1B Ca channels, depending on the gamma  subunit found in the heterodimer. beta 1-beta 4 subunits inhibited Ca channels when paired with gamma 1-gamma 3. However, beta 5 subunits only produced inhibition when paired with gamma 2. In contrast, heterodimers between beta 5 subunits and RGS (regulators of G-protein signaling) proteins containing GGL domains did not produce inhibition of Ca channels. However, GGL domain-containing RGS proteins (e.g., RGS6 and RGS11) did block the ability of Gbeta 5/gamma 2 heterodimers to inhibit Ca channels. Because all of the G-protein beta  subunits are found in the nervous system, we conclude that they may all potentially participate in Ca channel inhibition. The interaction of GGL-containing RGS proteins with Gbeta 5gamma 2 suggests a novel way in which Ca channels can be regulated.

Key words: heterotrimeric G-proteins; calcium channel; ion-channel modulation; RGS proteins; presynaptic inhibition; synaptic transmission


    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Activation of G-protein-coupled receptors (GPCRs) by neurotransmitters has been shown to induce the inhibition of several types of voltage-sensitive Ca channels, including alpha 1B (N-type), alpha 1A (P/Q-type), and alpha 1E (R-type) (Miller, 1998; Simen and Miller, 1998, 2000). The resulting reduction in Ca influx may be important for GPCR-mediated inhibition of neurotransmitter release (Miller, 1998). Investigations of the mechanisms underlying GPCR-mediated Ca channel inhibition have shown that different processes can occur. The best studied of these is rapid and is characterized by its voltage dependence (Hille, 1994; Miller, 1998). The view is widely held that Ca channel inhibition of this type is mediated by the direct binding of G-protein beta /gamma subunits to one or more sites on the Ca channel alpha 1 subunit (Herlitze et al., 1996; Ikeda, 1996; J. F. Zhang et al., 1996; Qin et al., 1997; Simen and Miller, 1998, 2000; Canti et al., 1999). According to this model, activation of any GPCR should produce inhibition of Ca channels, because beta /gamma subunits are always released. However, this is clearly not the case, and there are many examples of GPCR activation that does not produce voltage-dependent inhibition of Ca channels (Bernheim et al., 1991; Taussig et al., 1992; Shapiro and Hille, 1993; Hille, 1994; Shapiro et al., 1994; Liu et al., 1995; Margeta-Mitrovic et al., 1997). In many cases these GPCRs are linked to G-proteins of the alpha q/alpha 11 family. However, the reasons for this selectivity are not clear. One possibility is that not all combinations of beta /gamma subunits are equally effective in inhibiting Ca channels. There are at least 5 types of beta  subunits, all of which are found in the nervous system (Betty et al., 1998), and at least 11 types of gamma  subunits; therefore, many beta /gamma combinations are potentially possible (Morris and Malbon, 1999). Garcia et al. (1998) examined this question by analyzing the effects of expressing different beta  subunits in cultured rat superior cervical ganglion (SCG) neurons. They observed that only beta 1 and beta 2 produced strong voltage-dependent Ca channel inhibition, whereas beta 5 and, particularly, beta 3 and beta 4 were weak in this regard. Because Galpha q is often thought to associate with beta 5 (Fletcher et al., 1998), it could be argued that lack of effect of beta 5 was responsible for the modest Ca channel inhibition observed with GPCRs of this type. Recently, however, Ruiz-Velasco and Ikeda (2000) reexamined this question and observed that all beta  subunits could produce inhibition of Ca channels in rat sympathetic neurons under the appropriate conditions.

In the present series of experiments we examined this question further using cloned human alpha 1B (N-type) Ca channels and different combinations of beta /gamma subunits. Our data indicates that all of the beta  subunits can inhibit Ca channels, but that this is dependent on the nature of the gamma  subunit present in the beta /gamma heterodimer. Moreover, the effects of some beta /gamma combinations are influenced by RGS (regulators of G-protein signaling) proteins, suggesting a novel mechanism through which these proteins may regulate neuronal Ca channels.


    MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Expression constructs. Mouse Gbeta 4 (GenBank accession number M87286) was prepared from adult male CD4 mouse brain mRNA. Human Gbeta 1 (X04526), Gbeta 2 (NM_005273), Gbeta 3 (NM_002075), and Gbeta 5 (AF017656) were obtained from human embryonic kidney (HEK) cell line mRNA (Quick Prep Micro mRNA purification kit; Amersham Pharmacia Biotech, Piscataway, NJ). beta  subunit cDNAs were amplified from the isolated mRNA by reverse transcription-PCR (thermal cycling: 98°C, 20 min; 56°C, 1 min; 72°C, 1.5 min; 35 cycles, preceded by a 3 min 98°C denaturing) with SuperScript II reverse transcriptase (Life Technologies, Rockville, MD) and oligo-dT oligonucleotides and then with specific primers and TakaRa LA Taq DNA polymerase (PanVera, Madison, WI). Subunit specific primers used here were as follows: beta 1 forward (beta 1F), GCCGCCACCATGAGTGAGCTTGACCAGTTACGGCAGGAG; beta 1 reverse (beta 1R), CTTAGTTCCAGATCTTGAGGAAGCTATCCCA; beta 2F, GCCGCCACCA-TGAGTGAGCTGGAGCAACTGAG; beta 2R, CCATTAGTTCCAGATC-TTGAGGAAGG; beta 3F, GCCACCATGGAGCAACTGCGTCAGGAA-GC; beta 3R, CCACTTCCCTTTCTCCAGCCTCC; beta 4F, GCCACCATGA-GCGAGCTGGAGCAGCTGA; beta 4R, CTCCATGTATCATTGGAGA-ACAG; beta 5F, GCCGCCACCATGGCAACCGAGGGGCTGC; and beta 5R, GATGATTAGGCCCAGACTCTGAG.

All constructs contained an expression-optimized Kozak sequence (GCCACC) before the 5'-ATG start codon. The resulting amplification products were first cloned into pCRII/TOPO vector (Invitrogen, San Diego, CA) for verification. Verified constructs were directionally cloned into a mammalian expression vector driven by the cytomegalovirus (CMV) promoter (Gbeta 1 was cloned in pCMV6C; Gbeta 2, Gbeta 3, and Gbeta 5 were cloned in pcDNA3.1; and Gbeta 4 was cloned in pCR3.1). The resulting clones were verified by restriction enzyme digestion and automated DNA sequencing (ABI 377 sequencer; Perkin-Elmer, Oak Brook, IL). Ggamma 1 was subcloned in pCDNA1, Ggamma 2 in pCDM8.1, and Ggamma 3 in pCDNA1 (gifts from Dr. Katz, Caltech). Green fluorescent protein (GFP) vector is commercially available from Life Technologies.

The RGS11n construct encoding the N-terminal half of the RGS11 protein contains DEP and GGL domains, and the RGS11c construct encoding the C-terminal half of the RGS11 protein contains an RGS domain. They were generated by PCR (T7 primer with R11R, CTTCGTGGGGGCAGCCTCGAGGGGGGCATTCATGAC; and pcDNA3.1R primer with R11F, GTGGTGGAATTCGACCATGCCGCATCTGAG-GAAGATGGAGCGGGTGGTCGTGAGCATGCAGGACGTCATGAATGCCCCCACGGTGGCT) using pfu DNA polymerase (Stratagene, La Jolla, CA) and were subcloned into a pcDNA3.1 vector. The two constructs were designed to have the same sequence around the start codon as in full-length RGS11 to achieve similar expression levels. Full-length RGS11, RGS11Delta D, and RGS11*(PW274AS), full-length RGS6, RGS6Delta D, and RGS6*(D297A) constructs were tagged with an N-terminal hemagglutinin epitope and subcloned into the pcDNA3.1 vector as described (Snow et al., 1998, 1999). RGS2, RGS4, and untagged RGS11 constructs, cloned into the mammalian expression vector pcDNA3.1, were gifts from Drs. A. Gilman and A. Krumins (University of Texas Southwestern Medical Center).

Cell culture and transient transfection. The C2D7 cell line, derived from HEK293 cells stably expressing the N-type Ca channel alpha 1B, alpha 2delta , and beta 1-3 subunits (Simen and Miller, 1998, 2000), was kindly provided by SIBIA Neurosciences and kept in medium (11995DMEM, 1% penicillin/streptomycin, 5% bovine calf serum, 0.5 g/l geneticin, and 70 µl/500 ml hygromicin). The cells were transfected with 5 µg of G-protein beta  subunit, 5 µg of G-protein gamma  subunit, and 1 µg of GFP DNA, using the polyethylenimine method as described by Boussif et al. (1995). In RGS cotransfection experiments, different amounts of Gbeta , Ggamma , and RGS DNA were used as indicated in the text. Successfully transfected cells were identified by GFP fluorescence.

Electrophysiological recording. At 40-72 hr after transfection, total Ba2+ currents were measured using the whole-cell patch-clamp technique. The coverslips were mounted in a perfusion chamber and constantly perfused by a gravity feed system with a modified HEPES-balanced external solution (151 mM tetraethylammonium chloride, 10 mM HEPES, 5 mM BaCl2, 1 mM MgCl2, and 10 mM glucose, pH adjusted to 7.4 and osmolarity to 310 mOsm) to isolate the IBa. Pipettes of 3-5 MOmega were pulled from microhematocrit capillary tubes (VWR Scientific, West Chester, PA) with a Flaming-Brown P-97 micropipette puller (Sutter Instrument Co., Novato, CA). The pipette solution contained 100 mM CsCl, 1 mM MgCl2, 10 mM HEPES, 10 mM BAPTA, 3.6 mM MgATP, 14 mM phosphocreatine (CrP), 0.1 mM LiGTP, and 50 U/ml creatine phosphokinase (CrPK); pH was adjusted to 7.2 with Cs(OH), and osmolarity was near 290mOsm. The tip solution was similar to the pipette solution without MgATP, CrP, LiGTP, or CrPK.

IBa was measured and recorded with an Axopatch 200B (Axon Instruments, Foster City, CA) using the Clampex program (pClamp 6 software suite; Axon Instruments). Data were digitized at 10 kHz and filtered at 5 kHz. Series resistance was compensated to 70%, and currents were leak-corrected on-line using a P4 protocol. Prepulse experiments were performed using a prepulse protocol consisting of a 50 msec +10 mV depolarization test pulse from -80 mV holding potential with (test pulse 2) or without (test pulses 1) a 50 msec +80 mV prepulse (Fig. 1A). There was a 5 msec -80 mV interval between the prepulse and test pulse. Currents were analyzed off-line using the Clampfit program. Facilitation was indicated by calculating the "facilitation ratio" (P2/P1), which we defined as the peak current of test pulse 2 divided by the current of test pulse 1 at the same time point (See Simen and Miller, 1998). This time point was normally between 6 and 15 msec after the start of the depolarizing test pulse. All experiments and solutions were used at room temperature.

Statistical analysis for multiple comparisons was performed using one-way ANOVA followed by a nonparametric Kolmogorov-Smirnov test. The unpaired t test was used for two-group comparison. p < 0.01 was considered statistically significant.

Northern blots. Total RNA was isolated from transfected (48 hr) C2D7 cells using the guanidine thiocyanate-phenol method (Trizol reagent; Life Technologies). Total RNA from untransfected cells was used as a control. Twenty micrograms of RNA for each sample were separated on formaldehyde-agarose gels and transferred to Hybond-N+ nylon membranes (Amersham Pharmacia Biotech). Each beta  subunit was probed with a subunit-specific oligonucleotide (beta 1, TTCCCACTGGGTCGATGTTGTT-TGTG; beta 2, GGAGCAGATGTTGTCCAACC; beta 3, AATGAAGAGATTG-AAGTCAGGAGACAC; beta 4, TCCCGAACTTGTAATGATTT GTCCA; beta 5: CGTGCAGGGCATGGTGACCGCGTGCT). The probe was labeled with T4 polynucleotide kinase (New England Biolabs, Beverly, MA) and [gamma 32P]ATP (6000Ci/mmol; Amersham Pharmacia Biotech). Membranes were prehybridized for 2 hr at 42°C (6× SSPE, 5× Denhardt's solution, 0.1% SDS, and 100 µg/ml boiled salmon sperm DNA) and hybridized at 42°C overnight (prehybridization solution plus labeled probes). The blots were washed in 5× SSC and 0.5% SDS at room temperature for 10 min and in 0.5× SSC and 0.1% SDS at 42°C for 10-60 min.


    RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

We subcloned human G-protein beta 1, beta 2, beta 3, and beta 5 and mouse (m) beta 4 into CMV vectors. All beta  subunits were sequenced and matched sequences formerly reported, with the exception that the mbeta 4 sequence showed four differences from that reported in the database (M87286). As previously observed (Snow et al., 1999), there were two silent mutations at positions 433 (Aright-arrowG) and 634 (Gright-arrowC), and differences at positions 434 (Gright-arrowA) and 458 (Gright-arrowC) corresponded to Aspright-arrowAsn and Alaright-arrowPro substitutions. Three independent clones were sequenced, and all showed the same changes.

We examined the effects of overexpressing different G-protein beta  subunits on cloned human alpha 1B (N-type) Ca channels (alpha 1B-1, alpha 2delta , and beta 1-3) stably expressed in HEK293 cells (C2D7 cells). In control cells, a 50 msec depolarizing test pulse to +10 mV elicited a rapidly activating and slowly inactivating IBa, which was not significantly altered by a 50 msec prepulse to +80 mV (Fig. 1A). To study the ability of different G protein beta /gamma dimers to inhibit the IBa, we transiently transfected C2D7 cells with different G-protein beta  subunits, together with gamma 3 subunits and GFP DNA. Ba currents were only recorded from GFP fluorescent cells. Expression of beta 1gamma 3 subunits in C2D7 cells reduced the IBa amplitude and slowed its activation rate (Fig. 1B, trace 1). The inhibition was "relieved" by a depolarizing prepulse (Fig. 1B, trace 2). The resulting "facilitation ratio" (see Materials and Methods) has frequently been used as an index of voltage-dependent, membrane-delimited inhibition of Ca channels by G protein beta /gamma subunits (Simen and Miller, 1998, 2000). In addition, the I-V curve for the IBa was shifted to the left by ~10-15 mV after the prepulse (Fig. 1B, bottom traces). As did Garcia et al. (1998), we observed that both beta 1gamma 3 and beta 2gamma 3 inhibited N-type currents in a voltage dependent manner, with facilitation ratios of 1.76 ± 0.16 and 1.87 ± 0.21, respectively (Fig. 1B,C). In contrast to Garcia et al. (1998), we found that beta 4gamma 3 and beta 3gamma 3 also significantly inhibited the IBa (Fig. 1D,E). beta 4gamma 3 and beta 3gamma 3 produced facilitation ratios of 2.01 ± 0.18 and 1.50 ± 0.12, respectively. However, no effects were observed in cells transfected with Gbeta 5gamma 3 DNA (Fig. 1F). Moreover, overexpression of any beta  subunits alone failed to produce inhibition of the IBa (data not shown). To exclude the possibility that the inability of beta 5gamma 3 to inhibit the IBa was attributable to a failure to express the beta 5 subunit, total RNA was isolated from transfected cells and probed with beta  subunit-specific oligonucleotides. Each beta  subunit was expressed as a transcript of ~1.2 kb (Fig. 2).



View larger version (31K):
[in this window]
[in a new window]
 
Figure 1.   Effects of different G beta  subunits on barium current facilitation. Top panel, Superimposed IBa during a 50 msec depolarization to +10 mV from -80 mV holding potential, without (trace 1) and with (trace 2) a 50 msec +80 mV prepulse. Bottom panels, Leftward shift of the I-V curve after the prepulse (dashed gray line). Currents were recorded 40-72 hr after transfection of C2D7 cells with GFP alone (A) or with G-protein beta 1 (B), beta 2 (C), beta 3 (D), beta 4 (E), or beta 5 (F), expressed together with Ggamma 3.



View larger version (56K):
[in this window]
[in a new window]
 
Figure 2.   Northern blot of G protein beta  subunit expression. Total mRNA (20 µg) isolated from untransfected C2D7 cells (as control, C) and cells transfected with different G protein beta  subunits (as marked) were hybridized with subunit-specific oligonucleotide probes (see Materials and Methods). Positions of the RNA size standards (in kilobases) are shown on the left. Heterologously expressed Gbeta subunits are marked with an arrow on the right. Endogenous Gbeta subunits were expected to have similar sizes. However, because they were expressed in much lower amounts, they would not be detected under these experimental conditions.

To further assess the potential role of G-protein gamma  subunits, we investigated the ability of other combinations between beta 1-beta 4 and gamma 1-gamma 3 to inhibit the IBa. These results are summarized in Figure 3. For beta gamma 1 combinations, beta 1gamma 1 exhibited the largest facilitation ratio (1.72 ± 0.14). beta 2gamma 1, beta 3gamma 1,and beta 4gamma 1 exhibited smaller effects, although they were still significantly different from control (one-way ANOVA, p < 0.01). As with beta 5gamma 3, beta 5gamma 1 failed to inhibit the IBa. beta gamma 2 combinations showed similar facilitation ratios for beta 1-beta 4 as did beta gamma 3 and beta gamma 1 combinations. A striking difference, however, was that beta 5gamma 2 strongly inhibited the IBa, exhibiting a facilitation ratio of 1.76 ± 0.07. 



View larger version (24K):
[in this window]
[in a new window]
 
Figure 3.   Summary of facilitation ratios for barium current inhibition after transfection of different Gbeta gamma combinations. G-protein beta  subunits were coexpressed with Ggamma 1 (A), Ggamma 2 (B), and Ggamma 3 (C). Gbeta expressed alone did not produce facilitation of IBa, as represented by Gbeta 2 in B. Data are plotted as mean ± SEM; *p < 0.01, one-way ANOVA analysis followed by nonparametric Kolmogorov-Smirnov test (n = 7~15).

It is interesting to note that G protein gamma  subunits are not the only proteins that can potentially form heterodimers with beta -subunits. RGS6, 7, 9,and 11 belong to a subfamily of G protein alpha -subunit GTPase-activating proteins (GAPs) that contain a gamma -subunit-like (GGL) domain (Hepler, 1999; Siderovski et al., 1999). It has been shown that GGL domain-containing RGS proteins form heterodimers with Gbeta 5 (Snow et al., 1998, 1999; Posner et al., 1999), raising the possibility that beta 5/RGS heterodimers could effectively inhibit Ca channels or that RGS proteins could act as "antagonists" by inhibiting the interaction between gamma 2 and beta 5. The next series of experiments were designed to investigate these possibilities. Coexpression of the GGL domain containing RGS11 with Gbeta 5 did not result in Ca channel inhibition (data not shown). Furthermore, neither RGS11 nor Gbeta 5 expressed alone produced any effect on the IBa (Fig. 4A; data not shown for Gbeta 5 alone). Interestingly, however, we observed that coexpression of RGS6 or RGS11 with beta 5gamma 2 was able to antagonize the effects of the beta /gamma heterodimers (Fig. 5). Thus, increasing the ratio of RGS11 to gamma 2 in the transfection produced a dose-dependent reduction in the facilitation ratio observed (Fig. 4A). This inhibition was selective for the beta 5gamma 2 combination; when RGS11 was coexpressed at an 8:1 ratio to gamma 2, together with beta 2, no reduction in the effects of the beta 2gamma 2 subunits was observed (Fig. 4B). It has been shown that point mutations in the GGL domain (D297A in RGS6 and PW274AS in RGS11) abolish the interaction between GGL-containing RGS proteins and Gbeta 5 (Snow et al., 1999). Expression of full-length RGS6/11 cDNA constructs with these mutations failed to block the effects of Gbeta 5gamma 2 (Fig. 5), thus supporting the role of the GGL domain in the interaction between RGS11 and beta 5gamma 2.



View larger version (28K):
[in this window]
[in a new window]
 
Figure 4.   RGS11 antagonized the effects of beta 5gamma 2. Increasing the ratio of RGS11 to gamma 2 reduced the IBa facilitation ratio produced by beta 5gamma 2 (A). However, RGS11 did not antagonize the effects of beta 2gamma 2 (B). In the second set of experiments (B), 8 µg of RGS11 was cotransfected with 1 µg of beta 2gamma 2 or beta 5gamma 2. Numbers of experiments are in parentheses. Data are plotted as mean ± SEM; *p < 0.01, unpaired t test between beta 5gamma 2 and beta 5gamma 2RGS11.



View larger version (30K):
[in this window]
[in a new window]
 
Figure 5.   RGS6 and RGS11 antagonism of Gbeta 5gamma 2 facilitation of Ca currents depends on their GGL domains. RGS6 and RGS11 constructs were cotransfected with Gbeta 5gamma 2 at an 8:1 ratio. (RGS6* and RGS11* represent full-length cDNA constructs with mutations in the GGL domain that inhibit binding to beta 5; see Results and Snow et al., 1999). A, Typical current traces with (trace 2) or without (trace 1) prepulse. B, Summary of facilitation ratios for IBa inhibition after cotransfection with beta 5gamma 2 and different RGS constructs. Data are plotted as mean ± SEM; *p < 0.01, one-way ANOVA analysis followed by nonparametric Kolmogorov-Smirnov test (n = 6~15).

All four of the GGL-containing RGS proteins, RGS6, 7, 9, and 11, contain a DEP (dishevelled/Egl-10/pleckstrin) domain as well as GGL and RGS domains. To further answer the question of which domain(s) is involved in the interaction with Gbeta 5gamma 2, we made two constructs consisting of the N-terminal (RGS11n) and C-terminal (RGS11c) halves of the RGS11 protein, with RGS11n containing the DEP and GGL domains and RGS11c containing the RGS domain and a C-terminal tail (Fig. 6B). At an 8:1 ratio, cotransfection of the RGS11n construct reduced the facilitation ratio produced by Gbeta 5gamma 2 to a degree similar to that observed with the full-length RGS11. However, cotransfection of RGS11c did not reduce the facilitation ratio significantly (Fig. 6C). In accordance with this result, RGS2 and RGS4 proteins, which contain only an RGS domain, failed to reduce the facilitation ratio when coexpressed with Gbeta 5gamma 2 (Fig. 6C). To further address the question of whether the DEP domain is a requirement for interaction with Gbeta 5, the DEP domains of RGS6 and RGS11 were deleted. Both constructs blocked the facilitation by Gbeta 5gamma 2 to an extent similar to that of full-length RGS6 and RGS11 (Fig. 6C).



View larger version (38K):
[in this window]
[in a new window]
 
Figure 6.   RGS protein constructs have different abilities to antagonize IBa inhibition by beta 5gamma 2. Various RGS constructs were cotransfected with Gbeta 5gamma 2 at an 8:1 ratio. A, Typical current traces with (trace 2) or without (trace 1) prepulse. B, Schematic structures of different RGS protein constructs. Artificial linkers or termini are drawn in thick lines. Hatched boxes, DEP domain; open boxes, GGL domain; filled boxes, hemagglutinin (HA) epitope; gray boxes, RGS domain. C, Summary of facilitation ratios for IBa inhibition after cotransfection with beta 5gamma 2 and different RGS protein constructs. Data are plotted as mean ± SEM; *p < 0.01, one-way ANOVA analysis followed by nonparametric Kolmogorov-Smirnov test (n = 8~15).


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Voltage-dependent inhibition of Ca channels is thought to be mediated by direct binding of G protein beta /gamma subunits to one or more sites on the alpha 1 subunit of the Ca channel (Herlitze et al., 1996; Ikeda 1996; Simen and Miller, 1998, 2000). An important question is how selectivity can be imparted to this process. That this is indeed important is indicated by studies showing that the productive activation of some GPCRs, particularly those linked to the alpha q family of heterotrimeric G proteins, does not produce voltage dependent inhibition of Ca channels, or at least rather little in comparison with other receptors (see introductory remarks). Because the activation of all GPCRs presumably results in the release of beta /gamma subunits, it is unclear what factors underlie specificity. However, because the precise composition of the heterotrimeric G proteins that interact with each receptor presumably differs, this may dictate specificity in some manner that is not currently understood. One important possibility is that not all combinations of beta /gamma heterodimers are able to inhibit Ca channels. Considering that there are at least 5 different beta  subunits and at least 11 types of gamma  subunits, the number of possible combinations is very large (Morris and Malbon, 1999). Garcia et al. (1998), examined the ability of all of the known beta  subunits to produce Ca channel inhibition when they overexpressed them in rat SCG neurons. They observed that only beta 1 and beta 2 produced strong Ca channel inhibition. Our results complement those of Garcia et al. (1998) in certain important respects. We have shown that all of the beta  subunits can in fact produce strong Ca channel inhibition, but that this may depend critically on the nature of the gamma -subunit involved. For example, although beta 1-beta 4 are effective when combined with gamma 1, 2, or 3, beta 5 is only effective when expressed with gamma 2. Similar conclusions can be drawn from the recent work of Ruiz-Velasco and Ikeda (2000). These results indicate that it is possible that in the SCG neurons used by Garcia et al. (1998), gamma 2 was not highly expressed, or that any other gamma  subunits that form heterodimers with beta 5 are also probably ineffective (Watson et al., 1994, 1996). Other explanations are also possible (see below).

The observation that only gamma 2 was effective in combination with beta 5 is consistent with several other observations in the literature. It has been shown that beta 5 will associate with several different gamma  subunits, including gamma 2, 4, 5, and 7 (Watson et al., 1994, 1996). Comparison of the functional effects of these heterodimers is limited. However, beta 5gamma 2 was shown to be a far more effective activator of phospholipase C (PLC)-beta 2 than either beta 5gamma 4 or beta 5gamma 7 (S. Zhang et al., 1996). On the other hand, none of these combinations proved to be effective activators of the MAPK and JNK pathways, although they were all effective in combination with beta 1 (S. Zhang et al., 1996). Thus, beta 5-containing heterodimers are not effective in all signaling pathways. Clearly, in the case of N-type Ca channels, the beta 5/gamma 2 combination is effective, but beta 5gamma 1 and beta 5gamma 3 are not. Of particular interest in this regard are observations that beta 5gamma 2 heterodimers are selectively found in association with alpha q or other members of this family of heterotrimeric G proteins (Fletcher et al., 1998). Thus, activation of receptors such as the M1 muscarinic receptor, the ET1 endothelin receptor, or other alpha q linked receptors can be expected to release beta 5gamma 2 subunits (Lindorfer et al., 1998). Because we have now shown that these heterodimers are effective inhibitors of alpha 1B Ca channels, it is unlikely that this explains the ineffectiveness of alpha q-linked GPCRs in inhibiting Ca channels.

The structure of the beta 5 subunit is the most unusual of all of the beta  subunits, being only ~50% identical to beta 1-beta 4, all of which are very similar to one another (Morris and Malbon, 1999). It has recently been shown that the beta 5 subunit can associate not only with gamma  subunits but also with proteins of the RGS family that possess gamma  subunit-like GGL domains (Hepler, 1999; Siderovski et al., 1999). The question arises of the biological significance of these beta 5/RGS heterodimers. One possibility is that they might support the same effector signaling events as beta 5/gamma 2 heterodimers. However, as we demonstrate here, this does not necessarily appear to be the case. Coexpression of beta 5 with RGS11 did not produce Ca channel inhibition. It has been shown biochemically that overexpression of beta 5 (but not beta 1-beta 4) with GGL-containing RGS proteins does actually lead to the formation of tight complexes in the cytosol of cells (Snow et al., 1998, 1999; Posner et al., 1999; Liang et al., 2000). Thus, it is unlikely that the lack of effect of the RGS11 seen in our experiments is attributable to the lack of formation of heterodimers. Recently, Posner et al. (1999) and Snow et al. (1998) demonstrated that although heterodimers formed between RGS6, 7, or 11 and beta 5 possessed appreciable GAP activity, they were ineffective in activating or inhibiting adenylate cyclases I and II and were also unable to antagonize the ability of beta 1gamma 2 to activate cyclase. In addition, neither beta 5/RGS complex was able to activate PLC-beta 2, although high concentrations of the heterodimer had a small inhibitory effect on the enzyme activated by beta 1gamma 2 (Posner et al., 1999). Thus, the lack of effect of beta 5/RGS11 complexes on Ca channels mirrors other data indicating that these complexes are generally inactive in traditional assays of beta /gamma -mediated signal transduction.

On the other hand, it is also possible that GGL-containing RGS proteins might compete with gamma 2 for beta 5 subunits and therefore antagonize the effects of the beta 5gamma 2 heterodimer. Indeed, it has been proposed that GGL-containing RGS proteins have a higher affinity for Gbeta 5 than Ggamma 2 does, because conversion from phenylalanine (Phe-61) within Ggamma 2 to tryptophan (Trp-274) at the analogous position found within GGL domains of RGS proteins increases Gbeta 5/gamma 2 binding under low-detergent conditions (Snow et al., 1999). We have now obtained evidence for this competing interaction, although the relative affinities of the binding partners cannot be accurately assessed from our experiments. Thus, coexpression of both RGS6 and RGS11 blocked the inhibitory effects of beta 5gamma 2 on Ca channels, although they were unable to block the effects of beta 2gamma 2. The role of the GGL domains in these effects is clear from the fact that mutations that prevent binding of the GGL domain to beta 5 also prevented the effect of RGS6 and 11. Furthermore, when we cut the RGS11 proteins into two sections, the portion containing the GGL and DEP domains inhibited the effect of beta 5gamma 2, whereas the portion containing the RGS domain did not. The function of the DEP domain is unclear. It has been suggested that DEP domains may play a role in membrane targeting of proteins (Axelrod et al., 1998). However, in the present case, deletion of the DEP domains from RGS6 or 11 did not abolish their effects on beta 5gamma 2. Thus, our data are consistent with the possibility that GGL-containing RGS proteins may regulate beta 5gamma 2-dependent inhibition of Ca channels through interaction of their GGL domains with beta 5. In support of this possibility, beta 5/RGS6 and beta 5/RGS7 complexes have been isolated from the brain (Liang et al. 2000, Zhang and Simonds, 2000). It is also possible that the decreased effectiveness observed by Garcia et al. (1998) and Ruiz-Velasco and Ikeda (2000) when beta 5 was expressed in SCG neurons reflects the expression of GGL-containing RGS proteins in these neurons.

In summary, our results indicate that all of the known G-protein beta  subunits are capable of producing rapid, voltage-dependent inhibition of Ca channels, although this ability may depend on the type of gamma  -subunit found in the heterodimer. Because all of the beta  subunits are highly expressed in the nervous system (Betty et al., 1998), it is likely that they may all participate in the receptor-mediated regulation of Ca channels. Thus, the reasons why activation of some GPCRs does not produce strong Ca channel inhibition may not simply depend on the selectivity of beta /gamma heterodimers for Ca channel inhibition (Garcia et al., 1998). Our data also suggest that GGL-containing RGS proteins may act as antagonists of heterotrimeric G proteins in two ways. First, they can act as GAP proteins for G-protein alpha  subunits, and second, as we show here, they may act as antagonists of beta 5gamma 2 heterodimers through their interactions with beta 5 subunits.


    FOOTNOTES

Received June 1, 2000; revised July 10, 2000; accepted July 12, 2000.

This study was supported by US Public Health Service Grants DA-02121, DA-13141, DA-44840, MH-40165, NS-33826, and NS-21442. We thank Dr. C. Lee for helpful suggestions and comments throughout the project and D. Ren for excellent technical assistance. We are grateful to Drs. A. Gilman and A. Krumins for kindly providing cDNA for RGS proteins, to Dr. Katz for Ggamma subunit cDNA, and to SIBIA Neuroscience for cell lines expressing alpha 1B Ca channels.

Correspondence should be addressed to Dr. Richard J. Miller, Department of Neurobiology, Pharmacology, and Physiology, University of Chicago, 947 East 58th Street (MC 0926), Chicago, IL 60637. E-mail: rjmx{at}midway.uchicago.edu.


    REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

  • Axelrod JD, Miller JR, Shulman JM, Moon RT, Perrimon N (1998) Differential recruitment of Dishevelled provides signaling specificity in the planar cell polarity and Wingless signaling pathways. Genes Dev 12:2610-2622[Abstract/Free Full Text].
  • Bernheim L, Beech DJ, Hille B (1991) A diffusible second messenger mediates one of the pathways coupling receptors to calcium channels in rat sympathetic neurons. Neuron 6:859-867[ISI][Medline].
  • Betty M, Harnish SW, Rhodes KJ, Cockett MI (1998) Distribution of heterotrimeric G-protein beta  and gamma  subunits in the rat brain. Neurosci 85:475-486[ISI][Medline].
  • Boussif O, Lezoualch F, Zania MA, Mergny MD, Scherman D, Demeneix B, Behr JP (1995) A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc Natl Acad Sci USA 92:7297-7301[Abstract/Free Full Text].
  • Canti C, Page KM, Stephens GJ, Dolphin AC (1999) Identification of residues in the N terminus of alpha 1B critical for inhibition of the voltage-dependent calcium channel by Gbeta gamma . J Neurosci 19:6855-6864[Abstract/Free Full Text].
  • Fletcher JE, Lindorfer MA, De Filippo JM, Yasuda H, Guilmard M, Garrison JC (1998) The G-protein beta 5 subunit interacts selectively with the Gq alpha  subunit. J Biol Chem 273:636-644[Abstract/Free Full Text].
  • Garcia DE, Li B, Garcia-Ferreiro RE, Hernandez-Ochoa EO, Yan K, Gautam N, Catterall WA, Mackie K, Hille B (1998) G-protein beta -subunit specificity in the fast membrane delimited inhibition of Ca channels. J Neurosci 18:9163-9170[Abstract/Free Full Text].
  • Hepler JR (1999) Emerging roles for RGS proteins in cell signaling. Trends Pharmacol Sci 20:376-382[Medline].
  • Herlitze S, Garcia DE, Mackie K, Hille B, Scheuer T, Catterall WA (1996) Modulation of Ca channels by G-protein beta /gamma subunits. Nature 380:258-262[Medline].
  • Hille B (1994) Modulation of ion channel function by G-protein coupled receptors. Trends Neurosci 17:531-536[ISI][Medline].
  • Ikeda SR (1996) Voltage dependent modulation of N-type calcium channels by G-protein beta /gamma subunits. Nature 380:255-258[Medline].
  • Liang JJ, Chen HH, Jones PG, Khawaja XZ (2000) RGS7 complex formation and colocalization with the Gbeta 5 subunit in the adult rat brain and influence on Gbeta 5gamma 2-mediated PLCbeta signaling. J Neurosci Res 60:58-64[Medline].
  • Lindorfer MA, Myung CS, Savino Y, Yasuda H, Khazan R, Garrison JC (1998) Differential activity of the G-protein beta 5gamma 2 subunit at receptors and effectors. J Biol Chem 273:34429-34436[Abstract/Free Full Text].
  • Liu NJ, Xu T, Xu C, Li CQ, Yu YX, Kang HG, Han JS (1995) Cholecystokinin octapeptide reverses µ-opioid receptor mediated inhibition of calcium current in rat dorsal root ganglion neurons. J Pharmacol Exp Ther 275:1293-1299[Abstract/Free Full Text].
  • Margeta-Mitrovic M, Grigg JJ, Koyano K, Nakajima Y, Nakajima S (1997) Neurotensin and substance P inhibit low and high voltage activated Ca channels in cultured newborn rat nucleus basalis neurons. J Neurophysiol 78:1341-1352[Abstract/Free Full Text].
  • Miller RJ (1998) Presynaptic receptors. Annu Rev Pharmacol Toxicol 38:201-227[ISI][Medline].
  • Morris AJ, Malbon CC (1999) Physiological regulation of G-protein linked signalling. Physiol Rev 79:1373-1430[Abstract/Free Full Text].
  • Posner BA, Gilman AG, Harris BA (1999) Regulators of G-protein signalling 6 and 7. J Biol Chem 274:31087-31093[Abstract/Free Full Text].
  • Qin N, Platano D, Olcese R, Stefani E, Birnbaumer L (1997) Direct interaction of Gbeta gamma with a C-terminal Gbeta gamma -binding domain of the Ca2+ channel alpha 1 subunit is responsible for channel inhibition by G protein-coupled receptors. Proc Natl Acad Sci USA 4:8866-8871.
  • Ruiz-Velasco V, Ikeda SR (2000) Multiple G-protein beta gamma combinations produce voltage-dependent inhibition of N-type calcium channels in rat superior cervical ganglion neurons. J Neurosci 20:2183-2191[Abstract/Free Full Text].
  • Shapiro MS, Hille B (1993) Substance P and somatostatin inhibit calcium channels in rat sympathetic neurons via different G-protein pathways. Neuron 10:11-20[ISI][Medline].
  • Shapiro MS, Wollmuth LP, Hille B (1994) Angiotensin 11 inhibits calcium and M current channels in rat sympathetic neurons via G-proteins. Neuron 12:1319-1329[ISI][Medline].
  • Siderovski DP, Strockbine B, Behe CI (1999) Whither goest the RGS proteins? Crit Rev Biochem Mol Biol 34:215-251[ISI][Medline].
  • Simen AA, Miller RJ (1998) Structural features determining differential receptor regulation of neuronal Ca channels. J Neurosci 18:3689-3698[Abstract/Free Full Text].
  • Simen AA, Miller RJ (2000) Involvement of regions in domain I in the opioid receptor sensitivity of alpha1B Ca(2+) Channels. Mol Pharmacol 57:1064-1074[Abstract/Free Full Text].
  • Snow BE, Krumins AM, Brothers GM, Lee S, Wall MA, Chung S, Mangion J, Arya S, Gilman AG, Siderovske DP (1998) A G protein gamma  subunit-like domain shared between RGS11 and other RGS proteins specifies binding to Gbeta 5 subunits. Proc Natl Acad Sci USA 95:13307-13312[Abstract/Free Full Text].
  • Snow BE, Betts L, Mangion J, Sondek J, Siderovski DP (1999) Fidelity of G protein beta -subunit association by the G protein gamma -subunit-like domains of RGS6, RGS7, and RGS11. Proc Natl Acad Sci USA 96:6489-6494[Abstract/Free Full Text].
  • Taussig R, Sanchez R, Rifo M, Gilman AG, Belardetti F (1992) Inhibition of the omega -conotoxin sensitive calcium current by distinct G-proteins. Neuron 8:799-809[ISI][Medline].
  • Watson AJ, Katz A, Simon MI (1994) A fifth member of the mammalian G-protein beta -subunit family. J Biol Chem 269:22150-28160[Abstract/Free Full Text].
  • Watson AJ, Aragay AM, Slepak VZ, Simon MI (1996) A novel form of the G-protein beta  subunit Gbeta 5 is specifically expressed in the vertebrate retina J. Biol Chem 271:28154-28160[Abstract/Free Full Text].
  • Zhang JF, Ellinor PT, Aldrich RW, Tsien RW (1996) Multiple structural elements in voltage-dependent Ca2+ channels support their inhibition by G proteins. Neuron 17:991-1003[ISI][Medline].
  • Zhang JH, Simonds WF (2000) Copurification of brain G-protein beta5 with RGS6 and RGS7. J Neurosci 20(RC59):1-5[Abstract/Free Full Text].
  • Zhang S, Coso OA, Lee C, Gutkind JS, Simmonds WF (1996) Selective activation of effector pathways by brain specific Gprotein beta 5. J Biol Chem 271:33575-33579[Abstract/Free Full Text].


Copyright © 2000 Society for Neuroscience  0270-6474/00/20197143-06$05.00/0


This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
E. A. Yost, S. M. Mervine, J. L. Sabo, T. R. Hynes, and C. H. Berlot
Live Cell Analysis of G Protein beta5 Complex Formation, Function, and Targeting
Mol. Pharmacol., October 1, 2007; 72(4): 812 - 825.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
H. W. Tedford and G. W. Zamponi
Direct G Protein Modulation of Cav2 Calcium Channels
Pharmacol. Rev., December 1, 2006; 58(4): 837 - 862.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
H. W. Tedford, A. E. Kisilevsky, J. B. Peloquin, and G. W. Zamponi
Scanning Mutagenesis Reveals a Role for Serine 189 of the Heterotrimeric G-Protein Beta 1 Subunit in the Inhibition of N-Type Calcium Channels
J Neurophysiol, July 1, 2006; 96(1): 465 - 470.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
P. Koulen, J. Liu, E. Nixon, and C. Madry
Interaction between mGluR8 and Calcium Channels in Photoreceptors Is Sensitive to Pertussis Toxin and Occurs Via G Protein {beta}{gamma} Subunit Signaling
Invest. Ophthalmol. Vis. Sci., January 1, 2005; 46(1): 287 - 291.
[Abstract] [Full Text] [PDF]